SCHEMBL10925115

SCHEMBL10925115

CC(=O)Nc1ccc(N)c(C(=O)c2ccccc2Cl)c1

nearest known ligand 0.63

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ RECQL P46063 1/20 0.63
▸ KDM4E B2RXH2 2/20 0.51
▸ ALDH1A1 P00352 2/20 0.51
▸ HSD17B10 Q99714 2/20 0.51
▸ GLA P06280 1/20 0.51
▸ HPGD P15428 1/20 0.51
▸ MAPK13 O15264 3/20 0.50
▸ MAPK12 P53778 3/20 0.50
▸ MAPK11 Q15759 3/20 0.50
▸ MAPK14 Q16539 3/20 0.50
▸ FADS1 O60427 2/20 0.50
▸ HDAC1 Q13547 1/20 0.48
▸ MAPT P10636 1/20 0.48
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ JAK2 O60674 1/20 0.45
▸ JAK1 P23458 1/20 0.45
▸ NPC1 O15118 1/20 0.45
▸ RAB9A P51151 1/20 0.45
▸ RORC P51449 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8980390 0.79 ALDH1A1 (0.53) KDM4EALDH1A1HSD17B10GLAHPGD
SCHEMBL5459120 0.79 RORC (0.55) KDM4EALDH1A1GLAHDAC1MAPT
SCHEMBL9654244 0.78 RECQL (0.71) RECQLKDM4EALDH1A1MAPK13MAPK12
SCHEMBL29516764 0.78 RECQL (1.00) RECQLKDM4EALDH1A1MAPK14FADS1
SCHEMBL1261171 0.78 RECQL (0.75) RECQLKDM4EALDH1A1HSD17B10HPGD
SCHEMBL29849818 0.78 RECQL (0.75) RECQLKDM4EALDH1A1HSD17B10HPGD
SCHEMBL31597491 0.78 MYC (0.56) RECQLKDM4EALDH1A1HSD17B10GLA
SCHEMBL333313 0.78 RECQL (1.00) RECQLKDM4EALDH1A1MAPK14FADS1
SCHEMBL258439 0.78 MYC (0.56) RECQLKDM4EALDH1A1HSD17B10GLA
SCHEMBL2030008 0.78 MYC (0.56) RECQLKDM4EALDH1A1HSD17B10GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0072029-B1 TRIAZOLOBENZAZEPINES, PROCESS AND INTERMEDIATES FOR THEIR PREPARATION AND MEDICINES CONTAINING THEM F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1986-10-22 — — EP disclosed
US-4464300-A PSYCHOTROPIC, ANXIOLYTIC AGENTS HOFFMANN-LA ROCHE INC. (US) 1984-08-07 — — US disclosed
EP-0072029-A2 Triazolobenzazepines, process and intermediates for their preparation and medicines containing them F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1983-02-16 — — EP disclosed
Send feedback